Genetic knockdown and pharmacologic inhibition by the HDAC6 inhibitors markedly reduced melanoma tumor growth and combination therapy further reduced tumor growth compared with the individual effect of either agent and led to a greater infiltration of activated cytotoxic T cells (42). This evidence concerns the gene HDAC6 and neoplasm.